Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos Computational Biology|October 27, 2011
Ensemble-based computational approach discriminates functional activity of p53 cancer and rescue mutantsÖzlem Demir, Roberta Baronio, Faezeh Salehi, et al.Clinical Pharmacokinetics|March 31, 2026
Pharmacokinetic Comparability Assessment of Tixagevimab and Cilgavimab Developed for COVID-19 Prevention and Treatment Using Standard Exposure Metrics and Partial Area Under the CurveHuixia Zhang, Weifeng Tang, Samuel Sadow, et al.Biomolecules|August 29, 2024
Pyrimidine Triones as Potential Activators of p53 MutantsMaryam M Jebril Fallatah, Özlem Demir, Fiona Law, et al.Pediatrics|September 11, 2024
Safety and Pharmacokinetics of Nirsevimab in Immunocompromised ChildrenJoseph Domachowske, Ulrika Wählby Hamrén, Irfana Banu, et al.Lancet (London, England)|February 2, 2010
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohortLuca Gianni, Wolfgang Eiermann, Vladimir Semiglazov, et al.Angewandte Chemie (International Ed. in English)|April 14, 2015
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorPeter G K Clark, Lucas C C Vieira, Cynthia Tallant, et al.Nature Communications|January 31, 2013
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53Christopher D Wassman, Roberta Baronio, Özlem Demir, et al.Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|June 28, 2016
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorPeter G K Clark, Lucas C C Vieira, Cynthia Tallant, et al.Nature Genetics|December 21, 2022
A genome-wide CRISPR screen identifies CALCOCO2 as a regulator of beta cell function influencing type 2 diabetes riskAntje K Rottner, Yingying Ye, Elena Navarro-Guerrero, et al.Cell Chemical Biology|August 10, 2022
Discovery of compounds that reactivate p53 mutants in vitro and in vivoGeetha Durairaj, Özlem Demir, Bryant Lim, et al.Pageof 2